Status:
COMPLETED
Veterans Affairs Lowering Readmission in Heart Failure
Lead Sponsor:
VA Office of Research and Development
Conditions:
Heart Failure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Heart failure (HF) greatly increases mortality and lowers quality of life (QOL). HF is the most common indication for readmission in older adults and the most frequent reason for 30-day readmission. M...
Detailed Description
Heart failure (HF) greatly increases mortality and lowers quality of life (QOL). HF is the most common indication for readmission in older adults and the most frequent reason for 30-day readmission. M...
Eligibility Criteria
Inclusion
- All patients admitted with either systolic or diastolic HF will be identified through ongoing daily prospective manual search of admission records in VA NYHHS
- Men and women ( 21 years) being discharged after a HF admission will be eligible
- They must have an available phone
Exclusion
- Patients with poor short-term survival (\< 3 months)
- recent major surgery (\< 1 month)
- planned discharge to a long-term-care facility
- severe dementia or other serious psychiatric illness
- temporarily in the area
- those unable to provide consent, refusal to participate
- logistic or discretionary reasons (including participation in another study) will be excluded
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01144182
Start Date
October 1 2010
End Date
September 1 2013
Last Update
October 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA New York Harbor Health Care System
New York, New York, United States, 10010